Znfpc Spilhaus Center
Harare, Zimbabwe
NCT Number: NCT01956383
The protocol, approved by the Medical Research Council, was issued to assess the safety and efficacy of the non-surgical device for applying it to the national scale up of adult male circumcision in Zimbabwe
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Phase 3
Harare, Zimbabwe
Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline.
The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings.
Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PrePex™ device for adult male circumcision. The PrePex™ device facilitates adult male circumcision that is bloodless with no anesthesia and no sutures
Time frame: 9 weeks
To assess the safety of the PrePex device by means of the following parameters: Clinical significant adverse event rate when circumcision is performed by nurses
Time frame: 9 weeks
Time frame: 9 weeks
Observation of in-field usability of device using questionnaires
Time frame: 9 weeks
Obtain user feedback from nurses by questionnaires
Time frame: 9 weeks
Time frame: 9 weeks
Assess practicality and acceptability among nurses and patients using questionnaires.
Time frame: 9 weeks
Assess satisfaction of procedure among nurses and patients using questionnaires.
Time frame: 9 weeks
Ministry of Health and Child Welfare, Zimbabwe
Other
Phase III of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe (Nurses Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01956396
Blood-Borne Infections, Circumcision Adult
Harare, Zimbabwe
View Trial DetailsNCT01857700
Circumcision Adult, Voluntary Medical Male Circumcision
Kisumu, Nyanza, Kenya
View Trial DetailsNCT06793722
Circumcision, Circumcision Adult
Adıyaman, Turkey (Türkiye)
View Trial Details